Welcome!

News Feed Item

Lawsuit Settlement News Website Reports Updates with Actos, Bladder Cancer litigation, While Parent Company Fights Back

MT Services LLC informs plaintiffs on ongoing cases with Takeda Pharmaceutical, manufacturer of Actos (Pioglitazone hydrochloride) diabetes drug, seeking post-trial motions to lower $9Bil. verdict.

NEW ORLEANS, Aug. 11 2014 /PRNewswire/ -- MT Services LLC, The Lawsuit Settlement News Reporting Company, reported today that there are still claims being filed, lawsuits being heard, and possible settlements discussions in the works, for patients of the reputed bad pharmaceutical drug Actos. With about 2,500 lawsuits filed in 2014 alone, and 4,000 active lawsuits taking place in State and Federal Courts of California, Illinois, and Louisiana, the Actos litigation remains in full swing. Takeda Pharmaceuticals and partner Eli Lily are fighting back to defend their company with post-trial motions and defending "Bellwether Trials" vigorously.

MT Services is here to assist patients and plaintiffs with Actos information, including providing them with case updates, lawsuit cash advances for patients with lawyers, and assistance with finding a credible Actos lawyer or Actos law firm to ascertain if they have a valid claim. Clients seeking lawsuit funding, must retain a law firm first. 

To learn about MT Services' process and how we can help visit: http://www.lawsuitsettlementnews.com/about-our-products-and-services

After the 2014 $9 billion verdict against Actos, manufactures Takeda Pharmaceuticals and Eli Lily are in the process of filing post-trial motion, alleging that the Louisiana court's punitive damages were awarded out of "passion and prejudice" and they have requested a new trial. The motion claims the company is entitled to a new review because the award was unconstitutional and excessive. This was the first bellwether case for Actos, while thousands of similar allegation cases are at hand in the courts.

For more information about the Actos litigation and how MTS can help, visit: http://www.lawsuitsettlementnews.com/actos-cases

Actos has been successful in turning some cases around; a post-trial motion in May of 2013 reversed a $6.5 million dollar verdict when a plaintiff's expert testimony was excluded in the state court. In September of 2013, when a plaintiff did not properly take care of his own health, under Maryland's contributory negligence law a defense verdict was reached. Most recently, a plaintiff's smoking history was a huge factor in whether or not Actos was at fault for the development of the plaintiff's bladder cancer. This resulted in the defense verdict as well, as seemingly the jury could not ascertain the causation link between the Cancer and either the smoking or use of the possible bad drug, Actos.

Chris Janish, CEO of LSN commented on the Actos Litigation, "Any drug with a connection to Cancer is one of the highest concerns. Unfortunately, many Actos plaintiffs were also smokers and this is what makes some of those cases tough to decide whether through trial or via a settlement. None the less, lawyers in our network are working vigorously to work through all these issues and get Actos patients that have been diagnosed with bladder cancer just compensation. The major verdict by the plaintiff counsel for $9 billion speaks volumes about the potential awards available in Actos cases with bladder cancer."

According to LSN, the Actos litigation can go either way, but thousands of cases are still pending in courts and verdicts and preliminary settlement discussions have taken place according to sources close to the litigation. However, due to the severity of the injuries and other obtaining factors, LSN cannot ascertain what the average settlement value could be if Takeda were to agree to a global settlement. "This is one litigation where the range of settlement values could be a wide range depending on many factors, it is simply too early to speculate ultimately who will win – Takeda or the plaintiffs – or if a settlement is reached what a plaintiff can expect at this time", added Mr. Janish. 

MTS is providing lawsuit help including lawyer or law firm referrals for clients who request them, lawsuit cash advances (not to be considered lawsuit loans), surgical funding, and medical document retrieval for plaintiffs who need assistance getting medical records for their Actos potential litigation.

If you or a loved one has been injured by the Actos drug and need lawsuit help, including finding an Actos law firm, obtaining up to $50K in pre-settlement lawsuit funding, or obtaining surgical funding call right now to speak to a live agent at 877.571.0405. You may also fill out a quick application online at: lawsuitsettlementnews.com and an agent will contact you shortly.

Contact: Chris Janish, CEO
             Ph. 877.571.0405 

SOURCE MT Services LLC

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
"Space Monkey by Vivent Smart Home is a product that is a distributed cloud-based edge storage network. Vivent Smart Home, our parent company, is a smart home provider that places a lot of hard drives across homes in North America," explained JT Olds, Director of Engineering, and Brandon Crowfeather, Product Manager, at Vivint Smart Home, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Conference Guru has been named “Media Sponsor” of the 22nd International Cloud Expo, which will take place on June 5-7, 2018, at the Javits Center in New York, NY. A valuable conference experience generates new contacts, sales leads, potential strategic partners and potential investors; helps gather competitive intelligence and even provides inspiration for new products and services. Conference Guru works with conference organizers to pass great deals to gre...
DevOps is under attack because developers don’t want to mess with infrastructure. They will happily own their code into production, but want to use platforms instead of raw automation. That’s changing the landscape that we understand as DevOps with both architecture concepts (CloudNative) and process redefinition (SRE). Rob Hirschfeld’s recent work in Kubernetes operations has led to the conclusion that containers and related platforms have changed the way we should be thinking about DevOps and...
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform. In his session at @ThingsExpo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and shared the must-have mindsets for removing complexity from the develop...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous ar...
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
"Evatronix provides design services to companies that need to integrate the IoT technology in their products but they don't necessarily have the expertise, knowledge and design team to do so," explained Adam Morawiec, VP of Business Development at Evatronix, in this SYS-CON.tv interview at @ThingsExpo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
Widespread fragmentation is stalling the growth of the IIoT and making it difficult for partners to work together. The number of software platforms, apps, hardware and connectivity standards is creating paralysis among businesses that are afraid of being locked into a solution. EdgeX Foundry is unifying the community around a common IoT edge framework and an ecosystem of interoperable components.
"ZeroStack is a startup in Silicon Valley. We're solving a very interesting problem around bringing public cloud convenience with private cloud control for enterprises and mid-size companies," explained Kamesh Pemmaraju, VP of Product Management at ZeroStack, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Large industrial manufacturing organizations are adopting the agile principles of cloud software companies. The industrial manufacturing development process has not scaled over time. Now that design CAD teams are geographically distributed, centralizing their work is key. With large multi-gigabyte projects, outdated tools have stifled industrial team agility, time-to-market milestones, and impacted P&L stakeholders.
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Enterprises are adopting Kubernetes to accelerate the development and the delivery of cloud-native applications. However, sharing a Kubernetes cluster between members of the same team can be challenging. And, sharing clusters across multiple teams is even harder. Kubernetes offers several constructs to help implement segmentation and isolation. However, these primitives can be complex to understand and apply. As a result, it’s becoming common for enterprises to end up with several clusters. Thi...
"Infoblox does DNS, DHCP and IP address management for not only enterprise networks but cloud networks as well. Customers are looking for a single platform that can extend not only in their private enterprise environment but private cloud, public cloud, tracking all the IP space and everything that is going on in that environment," explained Steve Salo, Principal Systems Engineer at Infoblox, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Conventio...